Related Experiment Video
Updated: Jul 2, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
[Brimonidine intoxication in paediatrics. A presentation as intracranial hypertension syndrome]
M A Fernández Fernández1, M D Morillo Rojas, M A Ribó Golovart
1Servicio de Pediatría. Hospital Universitario Infantil Virgen del Rocío. Sevilla. España. Drlolo13@hotmail.com
Insights
Brimonidine, a lipophilic drug, can cause severe central nervous system (CNS) effects, especially in children. Due to potential lethal adverse events, its use is prohibited in infants and toddlers.
Area of Science:
- Ophthalmology
- Neurology
- Pharmacology
Background:
- Brimonidine's high lipophilicity facilitates corneal absorption and blood-brain barrier penetration.
- Understanding CNS penetration is crucial for assessing brimonidine's toxic potential.
Observation:
- Adverse effects of brimonidine use were evaluated.
- Particular attention was given to the pediatric population.
Findings:
- Brimonidine is contraindicated in infants and toddlers due to severe and potentially lethal adverse effects.
- Central nervous system (CNS) toxicity should be suspected in patients exhibiting compatible symptoms after brimonidine treatment, especially when organic disease is excluded.
Implications:
- Discontinuation of brimonidine and implementation of supportive care are necessary upon suspected toxicity.
- Clinical vigilance is required for pediatric patients using brimonidine.
- This highlights the critical need for cautious prescribing and monitoring of brimonidine in vulnerable populations.
Background:
Brimonidine is an extremely lipophilic drug which is absorbed very well through the cornea and thus crosses the blood-brain barrier. This is very important for any potential toxic effects on the CNS.
Objectives:
To show the adverse effects of brimonidine and advise the need for caution in its use in the paediatric population.
Conclusions:
Brimonidine is prohibited from use in toddlers and infants. Its adverse effects can be severe or lethal. It should be suspected in treated patients with compatible symptoms in whom organic disease has been ruled out. We must stop the use of brimonidine and adopt support measures.
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Bacterial Meningitis I: Introduction

